Sec Form 4 Filing - Griffin Noreen @ Immune Therapeutics, Inc. - 2016-03-01

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Griffin Noreen 2. Issuer Name and Ticker or Trading Symbol Immune Therapeutics, Inc. [ IMUN] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) CHIEF EXECUTIVE OFFICER (Last) (First) (Middle) 37 NORTH ORANGE AVENUE, SUITE 607 3. Date of Earliest Transaction (MM/DD/YY) 03/01/2016 (Street) ORLANDO, FL32801 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price COMMON STOCK 03/01/2016 J( 1 ) 500,000 ( 1 ) A $ 0 4,817,710 ( 2 ) D COMMON STOCK 03/10/2016 J( 3 ) 1,000,000 ( 3 ) D $ 0 3,817,710 ( 4 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Griffin Noreen 37 NORTH ORANGE AVENUE, SUITE 607 ORLANDO, FL32801 X CHIEF EXECUTIVE OFFICER Signatures GINA AUSTIN AUTHORIZED REPRESENTATIVE UNDER POWER OF ATTORNEY 03/30/2016 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Shares were issues as consideration for a portion past due salary and expenses. ( 2 )These shares include 2,685,000 held by the Griffin Family Trust, an irrevocable trust for the benefit of the reporting person's children and grandchildren; 704,009 held by Griffin Enterprises Group, LLC which is 50% owned by the reporting person and 50% owned and managed by Robert Wilson, the reporting person's son; and 1,428,701 owned by Noreen Griffin individually. ( 3 )These shares were originally issued in consideration for past compensation. The shares should have been cancelled in 2015 but were not cancelled due to technical difficulty obtaining proper documentation from the trustee of the Griffin Family Irrevocable Trust. ( 4 )These shares include 2,685,000 held by the Griffin Family Trust, an irrevocable trust for the benefit of the reporting person's children and grandchildren; 704,009 held by Griffin Enterprises Group, LLC which is 50% owned by the reporting person and 50% owned and managed by Robert Wilson, the reporting person's son; and 428,701 owned by Noreen Griffin individually.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.